Nice, FRANCE - 17 Jun `19Glisodin with UVB

Official Title: Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. A Randomized Double Blind Placebo Controlled Monocentric Study

In Brief: Glisodin 4 pills a day (1000mg) for 3 months then 2 pills a day (500 mg) for 3 months

Ages Eligible:  18 Years and older

Start Date: June 17, 2019

Completion Date (estimated): November 2, 2020

Status: Active, recruiting

Study ID from ClinicalTrials.gov: NCT03941808

Location: Centre Hospitalier Universitaire de Nice at Nice, Alpes-Maritime, France, 06001

Contact: To learn more about this study, you or your doctor may contact Passeron Thierry, PhD by phone +33492034688 or email passeron.t@chu-nice.fr. Please refer to this study by its NCT number.         

FAQOther Questions

  • Is there a special diet for vitiligo?

    In short, no.  Some people find that certain foods may worsen their vitiligo symptoms or that others may improve their skin condition. We found no scientific evidence that a sp...

  • Is vitiligo contagious?

    Vitiligo is NOT contagious. It cannot be passed on or caught from touching someone with vitiligo, shaking hands, swimming in the same pool, sharing towels, sitting next to someo...

  • Which diseases most commonly accompany vitiligo?

    According to a 10-year study, vitiligo patients have a statistically significant higher prevalence of other autoimmune conditions and dermatological disorders: hypothyroidism...